Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2025-09-26 00:00:00 ET · period of report 2025-09-24 · accession 0001213900-25-092558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-26 | 2025-09-24+ | CVKD | Szot Matthew K | CFO | S - Sale | $14.04 | -12.4K | 29.8K | -29% | -$174.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-25 | S | D | 10,900 | $14.05 | 18,933 | D | — | — | (F2) Represents shares of the Issuer's common stock sold by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.52, inclusive, having a weighted average price as shown in column 4 of $14.0534. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2025-09-24 | S | D | 1,500 | $14.00 | 29,833 | D | — | — | (F1) Represents shares of the Issuer's common stock sold by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.02, inclusive, having a weighted average price as shown in column 4 of $13.9953. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |